New York State Common Retirement Fund increased its holdings in shares of PetMed Express, Inc. (NASDAQ:PETS) by 8.2% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 22,400 shares of the company’s stock after buying an additional 1,699 shares during the quarter. New York State Common Retirement Fund owned 0.11% of PetMed Express worth $909,000 at the end of the most recent reporting period.
Several other hedge funds have also made changes to their positions in PETS. Acadian Asset Management LLC bought a new stake in shares of PetMed Express during the 2nd quarter worth $18,691,000. Oaktop Capital Management II L.P. bought a new stake in shares of PetMed Express during the 2nd quarter worth $15,171,000. Dimensional Fund Advisors LP lifted its position in shares of PetMed Express by 24.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 794,669 shares of the company’s stock worth $16,005,000 after buying an additional 153,709 shares during the last quarter. WBI Investments Inc. bought a new stake in shares of PetMed Express during the 2nd quarter worth $3,943,000. Finally, Prudential Financial Inc. lifted its position in shares of PetMed Express by 261.0% during the 2nd quarter. Prudential Financial Inc. now owns 126,294 shares of the company’s stock worth $5,127,000 after buying an additional 91,310 shares during the last quarter. Institutional investors and hedge funds own 81.30% of the company’s stock.
Several brokerages recently weighed in on PETS. Noble Financial restated a “hold” rating on shares of PetMed Express in a research report on Friday, October 27th. Zacks Investment Research upgraded PetMed Express from a “sell” rating to a “hold” rating and set a $50.00 price objective for the company in a research report on Friday, October 20th. ValuEngine downgraded PetMed Express from a “buy” rating to a “hold” rating in a research report on Monday, October 2nd. Credit Suisse Group restated an “underperform” rating and set a $19.00 price objective on shares of PetMed Express in a research report on Monday, October 2nd. Finally, Sidoti upgraded PetMed Express from a “neutral” rating to a “buy” rating and set a $47.00 price objective for the company in a research report on Thursday, August 24th. One analyst has rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $42.00.
PetMed Express, Inc. (NASDAQ PETS) opened at $36.56 on Monday. The firm has a market capitalization of $753.29, a PE ratio of 24.54, a PEG ratio of 2.21 and a beta of 1.09.
PetMed Express (NASDAQ:PETS) last issued its earnings results on Monday, October 23rd. The company reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.30 by $0.13. PetMed Express had a return on equity of 31.46% and a net margin of 11.58%. The business had revenue of $66.70 million during the quarter, compared to analysts’ expectations of $63.41 million. During the same quarter in the prior year, the firm earned $0.24 EPS. The business’s revenue for the quarter was up 9.7% compared to the same quarter last year. equities analysts predict that PetMed Express, Inc. will post 1.66 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, November 17th. Shareholders of record on Monday, November 6th will be issued a $0.20 dividend. The ex-dividend date of this dividend is Friday, November 3rd. This represents a $0.80 dividend on an annualized basis and a yield of 2.19%. PetMed Express’s payout ratio is presently 53.69%.
In other PetMed Express news, Director Ronald J. Korn sold 1,000 shares of the company’s stock in a transaction dated Friday, October 27th. The stock was sold at an average price of $35.57, for a total value of $35,570.00. Following the completion of the transaction, the director now owns 73,833 shares of the company’s stock, valued at approximately $2,626,239.81. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 4.00% of the stock is owned by corporate insiders.
COPYRIGHT VIOLATION NOTICE: This news story was posted by Community Financial News and is owned by of Community Financial News. If you are accessing this news story on another site, it was copied illegally and republished in violation of United States & international copyright & trademark laws. The correct version of this news story can be viewed at https://www.com-unik.info/2017/11/06/petmed-express-inc-pets-position-increased-by-new-york-state-common-retirement-fund.html.
PetMed Express Company Profile
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PetMed Express, Inc. (NASDAQ:PETS).
What are top analysts saying about PetMed Express Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for PetMed Express Inc. and related companies.